Viagra (Sildenafil) and Anesthesia: What Happens in the Perioperative Period

How Sildenafil Works and Why It Matters in the OR

Sildenafil is a selective PDE5 inhibitor. It blocks the enzyme that degrades cyclic GMP in vascular smooth muscle, allowing nitric oxide signaling to persist and producing sustained vasodilation. The same mechanism that relaxes penile vasculature also relaxes systemic and pulmonary vasculature, dropping both systemic vascular resistance and pulmonary artery pressure [1].

That dual action is clinically valuable when sildenafil is used for pulmonary arterial hypertension. In the surgical context, however, it creates a narrow margin for error. Anesthetic agents, spinal blocks, and several perioperative drugs use overlapping pathways to lower vascular tone. Add a drug on board that has already maximally inhibited PDE5 and the blood pressure response can become unpredictable.

The Pharmacokinetic Window That Matters

Sildenafil's plasma half-life is 3 to 5 hours in healthy adults [2]. Its primary active metabolite, N-desmethylsildenafil, carries roughly 50 percent of the parent compound's potency and adds another 4 hours of pharmacodynamic exposure. In older patients or those with hepatic impairment, clearance slows further, extending that window.

A 100 mg dose taken the evening before an 8 a.m. Surgery may still carry measurable plasma concentrations at the time of induction. That is why the standard clinical instruction is a full 24-hour cessation, not simply "don't take it the morning of surgery."

What the FDA Label States

The FDA-approved prescribing information for sildenafil states directly: "The use of VIAGRA with other PDE5 inhibitors or organic nitrates in any form is contraindicated" [2]. The label further warns that sildenafil potentiates the hypotensive effect of nitrates and that this effect may be observed up to 24 hours after sildenafil administration. Anesthesiologists reference this label when constructing preoperative medication protocols.

The Nitrate Interaction: An Absolute Contraindication

The sildenafil-nitrate combination is one of the few absolute pharmacodynamic contraindications in all of medicine. Both drugs increase cyclic GMP in vascular smooth muscle through different entry points: nitrates donate nitric oxide directly, and sildenafil prevents its downstream degradation. Together they produce an additive effect on vasodilation that exceeds what either drug causes alone [3].

Clinical Data on the Magnitude of Blood Pressure Drop

A pharmacodynamic study published in the Journal of the American College of Cardiology measured the blood pressure effect of sublingual nitroglycerin 0.4 mg given 1 hour after sildenafil 100 mg in healthy volunteers. Mean supine systolic blood pressure fell by 36 mmHg in the sildenafil-plus-nitroglycerin group compared with 18 mmHg in the nitroglycerin-alone group [3]. Standing systolic blood pressure dropped by more than 50 mmHg in some subjects.

In the perioperative setting, nitroglycerin is a first-line agent for intraoperative hypertension and for coronary vasospasm during cardiac surgery. If a patient has taken sildenafil within 24 hours and receives nitroglycerin on the table, the anesthesiologist has lost that tool entirely. Using it risks hypotension severe enough to require vasopressor rescue.

What to Use Instead of Nitroglycerin

When nitrates cannot be used, the anesthesiologist typically reaches for:

• Nicardipine (calcium channel blocker) for acute intraoperative hypertension
• Clevidipine for continuous blood pressure control in cardiac surgery
• Phenylephrine or norepinephrine to treat hypotension (vasoconstrictors, not vasodilators)

The American College of Cardiology and American Heart Association 2014 Perioperative Guideline notes that "management of hemodynamic instability in patients on PDE5 inhibitors requires avoidance of nitrates and use of alpha-adrenergic agonists for hypotension" [4].

Anesthetic Agents and Sildenafil: Overlapping Hemodynamic Effects

General Anesthesia

Most volatile anesthetic agents (sevoflurane, desflurane, isoflurane) reduce systemic vascular resistance and myocardial contractility through calcium channel modulation and direct smooth muscle effects. Propofol induction routinely drops mean arterial pressure by 20 to 30 percent, even in healthy patients [5]. Sildenafil on board at induction shifts the baseline blood pressure lower before any anesthetic agent is given, narrowing the safe corridor.

A 2014 analysis in Anesthesia and Analgesia reviewed cases of refractory hypotension during general anesthesia and identified PDE5 inhibitor use within 24 hours as an independent risk factor. The authors recommended routine preoperative screening for PDE5 inhibitor use as part of medication reconciliation [5].

Spinal and Epidural Anesthesia

Neuraxial blockade causes sympathetic denervation below the level of the block, reducing venous return and systemic vascular resistance within minutes of injection. A spinal block for a hip replacement may drop systolic blood pressure by 20 to 40 mmHg in an otherwise healthy patient. The sildenafil-spinal combination compounds that drop.

Case reports have described clinically significant hypotension requiring vasopressor infusions in patients who disclosed PDE5 inhibitor use only after positioning for spinal anesthesia. Early disclosure prevents the problem. Late disclosure forces reactive management.

Regional Blocks With Epinephrine-Containing Solutions

Epinephrine is frequently added to local anesthetics to prolong block duration and provide a marker for intravascular injection. The interaction here is indirect: epinephrine can raise heart rate, and sildenafil's vasodilatory effect may blunt the alpha-adrenergic compensatory response if epinephrine is absorbed systemically. The net clinical effect is less predictable hemodynamics during the block period.

Pulmonary Arterial Hypertension: A Different Risk Profile

Patients with pulmonary arterial hypertension (PAH) are sometimes prescribed sildenafil (as Revatio, 20 mg three times daily) as a disease-modifying therapy. For these patients, stopping sildenafil perioperatively carries its own risk: rebound pulmonary hypertension and right heart failure [6].

The SUPER-1 trial (N=277) demonstrated that sildenafil 20 mg, 40 mg, and 80 mg three times daily each produced statistically significant improvements in 6-minute walk distance and pulmonary vascular resistance versus placebo at 12 weeks [6]. Interrupting this therapy abruptly in a perioperative patient with severe PAH may precipitate right ventricular decompensation.

For PAH patients, the decision to continue or hold sildenafil perioperatively requires a team approach involving the pulmonologist, cardiologist, and anesthesiologist. Continuous IV sildenafil or inhaled prostacyclins may bridge the gap. This population is categorically different from the erectile dysfunction patient taking sildenafil on demand.

Preoperative Disclosure: What Patients Need to Know

Sildenafil taken for erectile dysfunction is often self-administered without a standing prescription in the clinical record. Patients may not think to mention it on their preoperative medication list because they do not take it daily. That gap creates genuine risk.

The Three Things to Tell Your Surgical Team

1. That you take sildenafil or any PDE5 inhibitor (tadalafil, vardenafil, avanafil), even occasionally.
2. The last dose you took and the amount.
3. Whether you also use any nitrate-containing medications, including sublingual nitroglycerin spray for chest pain.

Anesthesia providers ask about all medications at the preoperative visit, but patients underreport as-needed drugs at a higher rate than daily medications. A 2019 survey in the British Journal of Anaesthesia found that 23 percent of patients failed to disclose at least one prescription or over-the-counter drug at preoperative assessment [7].

The 24-Hour Rule in Practice

For elective surgery: stop sildenafil at least 24 hours before the scheduled procedure. If a 25 mg dose was taken and surgery is the next morning, most anesthesiologists consider that borderline and will delay the case if the patient is high-risk cardiovascularly.

For emergency surgery: the anesthesiologist must be told immediately. They will avoid nitrates, prepare vasopressors at the bedside, and may choose a technique that minimizes hemodynamic swings. Knowing the drug is on board changes the anesthetic plan.

Alcohol and Sildenafil in the Perioperative Context

Sildenafil and alcohol both cause vasodilation and blood pressure reduction. Combined use amplifies postural hypotension, dizziness, and flushing. The FDA label for sildenafil notes that co-administration with alcohol (0.5 g/kg, roughly two drinks) increased the rate of adverse events including orthostatic hypotension [2].

In the perioperative window, alcohol consumption matters because:

• Chronic alcohol use induces cytochrome P450 3A4 and 2C9, potentially altering sildenafil metabolism.
• Acute alcohol ingestion before surgery raises aspiration risk independently.
• Alcohol combined with sildenafil the night before a procedure lowers the blood pressure baseline at induction.

Patients should be counseled to avoid alcohol for at least 4 to 6 hours before taking sildenafil and to follow standard NPO (nothing by mouth) instructions before any surgical procedure regardless of sildenafil use.

Other Perioperative Drug Interactions With Sildenafil

CYP3A4 Inhibitors and Inducers

Sildenafil is metabolized primarily by cytochrome P450 3A4 and secondarily by 2C9 [2]. Several drugs commonly used perioperatively affect these enzymes:

• Fluconazole (antifungal, sometimes given prophylactically): CYP3A4 and 2C9 inhibitor; increases sildenafil plasma levels, prolonging its effect.
• Erythromycin or clarithromycin (used for surgical prophylaxis in penicillin-allergic patients): CYP3A4 inhibitors; raise sildenafil exposure.
• Rifampin (occasionally used for MRSA protocols): potent CYP3A4 inducer; reduces sildenafil levels significantly.

If a patient on sildenafil receives a CYP3A4 inhibitor in the perioperative period, assume prolonged sildenafil activity and extend the nitrate avoidance window accordingly.

Alpha-Blockers

Alpha-blockers such as tamsulosin (commonly prescribed for benign prostatic hyperplasia) and doxazosin cause vasodilation by blocking alpha-1 adrenergic receptors. The FDA label for sildenafil warns that combining it with alpha-blockers can cause symptomatic hypotension [2]. In surgical patients, this triad of sildenafil, alpha-blocker, and induction agent creates compounding vasodilatory pressure that may require early vasopressor support.

Antihypertensives

Most antihypertensive agents have additive blood pressure-lowering effects with sildenafil. The clinical concern in the OR is patients who arrive already on ACE inhibitors, angiotensin receptor blockers, or calcium channel blockers and who also have sildenafil on board. Each of these agents independently blunts the compensatory vasoconstriction response to induction hypotension [8].

A pragmatic approach: ask explicitly about all cardiovascular and erectile dysfunction medications at the preoperative visit. Treat sildenafil as equivalent to an antihypertensive when calculating expected hemodynamic response to induction.

Monitoring and Management Protocols Intraoperatively

When sildenafil use within 24 hours is confirmed preoperatively, standard of care modifications include [4]:

• Arterial line placement for beat-to-beat blood pressure monitoring in moderate-to-high-risk cases.
• Vasopressor (phenylephrine or norepinephrine) drawn up and ready at induction, not just available on the shelf.
• Strict avoidance of nitroglycerin and isosorbide dinitrate for the duration of the case.
• Aggressive pre-induction fluid loading when spinal or epidural anesthesia is planned.
• Slower induction titration with propofol or etomidate rather than a rapid bolus technique.

These are risk-mitigation steps, not reasons to cancel surgery. Elective procedures should simply require the patient to stop sildenafil 24 hours prior. The intraoperative protocol above applies primarily to emergency cases or cases where disclosure was late.

Postoperative Period and Resuming Sildenafil

Sildenafil can generally be resumed once the patient is hemodynamically stable, off vasopressors, and no longer requiring nitrate-based therapy for pain or cardiac management. For most outpatient elective procedures, that means resuming as soon as the next day.

For cardiac surgery patients or those who required prolonged vasopressor support postoperatively, the attending physician should clear resumption of sildenafil explicitly before the patient restarts it. Patients discharged with nitroglycerin spray for chest pain must be counseled that sildenafil remains contraindicated while that prescription is active [2].

The FDA label specifies that 25 mg is the starting dose for patients on medications that may alter sildenafil pharmacokinetics. For older adults recovering from surgery who are starting sildenafil for the first time post-procedure, 25 mg is the appropriate initial dose.